PUTNAM INVESTMENTS LLC - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 80 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PUTNAM INVESTMENTS LLC ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$329,526
-48.3%
29,501
-0.9%
0.00%0.0%
Q2 2023$636,779
-48.7%
29,756
-3.0%
0.00%
-50.0%
Q1 2023$1,240,901
-16.6%
30,685
-4.1%
0.00%
-33.3%
Q4 2022$1,487,896
-10.4%
31,984
-0.1%
0.00%0.0%
Q3 2022$1,660,000
-18.3%
32,002
-25.6%
0.00%
-25.0%
Q2 2022$2,033,000
+6.9%
43,003
+61.0%
0.00%
+33.3%
Q1 2022$1,901,000
-11.5%
26,710
-7.1%
0.00%0.0%
Q4 2021$2,149,000
+40.6%
28,736
-32.0%
0.00%0.0%
Q3 2015$1,528,000
-17.5%
42,278
+2.6%
0.00%
-25.0%
Q2 2015$1,853,000
+138.5%
41,191
+62.2%
0.00%
+100.0%
Q1 2015$777,000
-41.9%
25,393
-3.4%
0.00%
-33.3%
Q4 2014$1,337,000
+27.8%
26,284
-0.5%
0.00%
+50.0%
Q3 2014$1,046,000
-6.4%
26,427
+1.8%
0.00%0.0%
Q2 2014$1,118,000
+7.8%
25,961
+0.1%
0.00%0.0%
Q1 2014$1,037,00025,9290.00%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q1 2014
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 858,811$36,156,00010.56%
Fairmount Funds Management LLC 150,433$6,333,0002.26%
ARMISTICE CAPITAL, LLC 1,356,000$57,088,0001.94%
FARALLON CAPITAL MANAGEMENT LLC 1,775,000$74,728,0000.45%
Virtus ETF Advisers LLC 14,321$603,0000.25%
Granahan Investment Management 231,071$9,728,0000.22%
JACOBS LEVY EQUITY MANAGEMENT, INC 248,320$10,454,0000.09%
ACADIAN ASSET MANAGEMENT LLC 467,514$19,684,0000.08%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 126$5,0000.08%
AIGEN INVESTMENT MANAGEMENT, LP 12,854$541,0000.07%
View complete list of ENANTA PHARMACEUTICALS INC shareholders